We are just 4 months short of 2019 and it’s probably a good time to summarize some of the most innovative medical devices of the year gone by. Let’s take a brief look at some of them.
An FDA-approved broad companion diagnostic, FoundationOne CDx is used for solid tumours, including colorectal, breast, ovarian and melanoma. It is developed by Foundation medicine and designed to give physicians clinically actionable information. Each test has microsatellite instability and tumour mutational burden to help make immunotherapy decisions.
Omnigraft Dermal Regeneration Matrix
Developed by Integra Lifesciences, the Omnigraft Dermal Regeneration Matrix is an advanced bilayer dermal regeneration matrix that treats diabetic foot ulcers. According to the company, it is the only FDA-approved product that can regenerate native dermal tissue. The patch has a built-in silicone layer that serves as a temporary epidermal layer and provides immediate coverage for wound protection. It can be removed between two and three weeks. Under the silicone layer is a collagen/chrondroitin-6-sulfate matrix that acts as a dermal replacement layer. The Omnigraft features a bioengineered scaffold that promotes dermal regeneration and is designed with a controlled porosity and degradation rate. It can be used for treating partial and full thickness neuropathic diabetic foot ulcers that are more than six weeks old with no capsule, tendon or bone showing.
Keep watching this space to know more about such innovative medical technology devices of 2018.